
Retatrutide is a GGG tri-agonist that targets GLP-1 and GIP receptors, akin to standard GLP-1 agonists, but also uniquely activates the glucagon receptor. This extra receptor interaction enhances glucagon production, leading to the breakdown of stored fats and glycogen, thereby increasing basal metabolism for more consistent fat loss. Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.

ANADROL 50 (USA WAREHOUSE)
LIGANDROL 10 (LDG-4033 USA WAREHOUSE)
CIALIS 20 (USA WAREHOUSE)
PROVIRON 25 (USA WAREHOUSE)
CYPIOTEST 300 (USA WAREHOUSE)
CABASER 0.50 (USA WAREHOUSE)
HMG 75iu/vial 10vials kits (USA WAREHOUSE) 

